Polsinelli Podcasts - FDA Denies Amgen Citizen Petition in Biosimilar Dispute
In a recent hearing held in Amgen v. Hospira, the parties offered arguments on some novel issues relating to litigation under the BPCIA, particularly: - ..Whether a reference product sponsor (“RPS”) can compel a...more